Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — Strategic Asset Allocation Index
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Strategic Asset Allocation Index of 19.6% as of June 2023. Strategic assets (PP&E of CN¥1.46 Billion plus long-term investments of CN¥-) total CN¥1.46 Billion, measured against net assets of CN¥7.44 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603567 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Heilongjiang ZBD Pharmaceutical Co Ltd Strategic Asset Allocation Index (2012–2021)
This chart shows how Heilongjiang ZBD Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 10 annual periods from 2012 to 2021. As of June 2023, the index stands at 19.6%, representing strategic assets of CN¥1.46 Billion against net assets of CN¥7.44 Billion CNY. For live market cap and overall valuation, see market cap of Heilongjiang ZBD Pharmaceutical Co Ltd.
Annual Strategic Asset Allocation Index for Heilongjiang ZBD Pharmaceutical Co Ltd (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Heilongjiang ZBD Pharmaceutical Co Ltd from 2012 to 2021, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 603567 net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 20.6% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥7.05 Billion | ▼ -5.9 pp |
| 2020 | 26.5% | CN¥1.46 Billion | CN¥1.46 Billion | CN¥- | CN¥5.50 Billion | ▼ -3.0 pp |
| 2019 | 29.5% | CN¥1.55 Billion | CN¥1.55 Billion | CN¥- | CN¥5.25 Billion | ▼ -20.7 pp |
| 2018 | 50.2% | CN¥2.50 Billion | CN¥2.44 Billion | CN¥60.65 Million | CN¥4.98 Billion | ▲ +8.6 pp |
| 2017 | 41.6% | CN¥1.95 Billion | CN¥1.89 Billion | CN¥60.00 Million | CN¥4.68 Billion | ▲ +9.0 pp |
| 2016 | 32.6% | CN¥1.40 Billion | CN¥1.34 Billion | CN¥60.00 Million | CN¥4.31 Billion | ▼ -2.0 pp |
| 2015 | 34.6% | CN¥1.38 Billion | CN¥1.32 Billion | CN¥61.00 Million | CN¥3.98 Billion | ▼ -27.4 pp |
| 2014 | 62.0% | CN¥1.35 Billion | CN¥1.35 Billion | CN¥- | CN¥2.17 Billion | ▼ -3.3 pp |
| 2013 | 65.3% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥1.75 Billion | ▼ -0.7 pp |
| 2012 | 66.0% | CN¥871.32 Million | CN¥871.32 Million | CN¥- | CN¥1.32 Billion | — |